Sorry, you need to enable JavaScript to visit this website.

Study of Marstacimab in Men With Hemophilia

A Multicenter, Open-Label, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Subcutaneous or Intravenous PF-06741086 in Subjects With Severe Hemophilia

Category & Conditions: Rare Diseases
Medicine: marstacimab (PF-06741086) Identifier (NCT): NCT02974855
Protocol ID: B7841002
Open Plain Language Summary Result: Click here